New imaging study tracks cancer clones to outsmart drug resistance
NCT ID NCT07302763
First seen Jan 04, 2026 · Last updated May 21, 2026 · Updated 21 times
Summary
This study uses special PET scans to see how each individual prostate cancer tumor (metastasis) responds to treatment. Researchers will scan 45 men with advanced prostate cancer before, during, and after therapy to find out why some tumors shrink while others grow. The goal is to better understand treatment resistance and guide future therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MCRPC (METASTATIC CASTRATION-RESISTANT PROSTATE CANCER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Québec-Université Laval
RECRUITINGQuébec, Quebec, G1J1Z4, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.